| Baseline Use of Concomitant Psychotropic Medications to Treat Schizophrenia in the CATIE Trial / | Chakos, Miranda H. et al | 1094-1101 | 2006.08.07 | - | |
| Interrelationships of Psychiatric Symptom Severity, Medical Comorbidity, and Functioning in Schizophrenia / | Chwastiak, Lydia A. et al | 1102-1109 | 2006.08.07 | - | |
| Substance Use and Psychosocial Functioning in Schizophrenia Among New Enrollees in the NIMH CATIE Study / | Swartz, Marvin S. et al | 1110-1116 | 2006.08.07 | - | |
| Components and Correlates of Family Burden in Schizophrenia / | Perlick, Deborah A. et al | 1117-1125 | 2006.08.07 | - | |
| Disparities in Hospitalization for Diabetes Among Persons With and Without Co-occurring Mental Disorders / | Sullivan, Greer. et al | 1126-1131 | 2006.08.07 | - | |
| Incidence, Prevalence, and Surveillance for Diabetes in New York State Psychiatric Hospitals, 1997-2004 / | Citrome, Leslie. et al | 1132-1139 | 2006.08.07 | - | |
| Medical Comorbidity in Bipolar Disorder: Implications for Functional Outcomes and Health Service Utilization / | McIntyre, Roger S. et al | 1140-1144 | 2006.08.07 | - | |
| Treatment of Cardiac Risk Factors Among Patients With Schizophrenia and Diabetes / | Weiss, Anthony P. et al | 1145-1152 | 2006.08.07 | - | |
| The Decision to Adopt Evidence-Based and Other Innovative Mental Health Practices: Risky Business? / | Panzano, Phyllis C. ;, Roth, Dee | 1153-1161 | 2006.08.07 | - | |
| Transformational and Transactional Leadership: Association With Attitudes Toward Evidence-Based Practice / | Aarons, Gregory A. | 1162-1169 | 2006.08.07 | - | |
